title: In patients with lymphoid tumours recovering from the autoimmune complications of fludarabine, relapse may be triggered by conventional chemotherapy.
authors.forename: J
authors.initials: J
authors.lastname: Orchard
authors.forename: S
authors.initials: S
authors.lastname: Bolam
authors.forename: H
authors.initials: H
authors.lastname: Myint
authors.forename: D G
authors.initials: DG
authors.lastname: Oscier
authors.forename: T J
authors.initials: TJ
authors.lastname: Hamblin
mesh_terms: D000368:Aged; D000744:Anemia, Hemolytic, Autoimmune / Q000139:chemically induced*; D000970:Antineoplastic Agents / Q000009:adverse effects*; D005260:Female; D019337:Hematologic Neoplasms / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D014740:Vidarabine / Q000009:adverse effects / Q000031:analogs & derivatives*
chemical_list: D000970:Antineoplastic Agents; D014740:Vidarabine; C024352:fludarabine